-
Omada Health reports 50-54% revenue growth in fourth quarter
-
Wells Fargo Starts Omada Health Inc (OMDA) at Equal Weight
-
Omada Health reports weight loss results from GLP-1 companion program
-
Evercore ISI Removes Omada Health Inc (OMDA) from Tactical Outperform List
-
Omada Health, Inc. (OMDA) Reports Q3 Loss of $0.06
-
Omada Health, Inc. (OMDA) Reports Q3 Loss of $0.06
-
Baird Starts Omada Health Inc (OMDA) at Neutral, 'some factors that may heighten risk and constrain investor interest'
-
Omada Health Inc (OMDA) PT Raised to $31 at Goldman Sachs
-
Omada Health Inc (OMDA) PT Lowered to $20 at Freedom Broker
-
Omada Health, Inc. (OMDA) Reports Q2 Loss of $0.24, provides guidance
-
15 names that Morgan Stanley’s analysts expect to move meaningfully on earnings
-
Freedom Broker Starts Omada Health Inc (OMDA) at Buy
-
Needham Starts Omada Health Inc (OMDA) at Buy
-
Evercore ISI Starts Omada Health Inc (OMDA) at Outperform
-
Canaccord Genuity Starts Omada Health Inc (OMDA) at Buy
-
Barclays Starts Omada Health Inc (OMDA) at Overweight
-
Morgan Stanley Starts Omada Health Inc (OMDA) at Overweight
-
JPMorgan Starts Omada Health Inc (OMDA) at Overweight
-
Goldman Sachs Starts Omada Health Inc (OMDA) at Buy
-
Omada Health (OMDA) Opens At $23, IPO Priced At $19
-
Omada Health (OMDA) IPO indicated to open at $22 after pricing at $19
-
Omada Health (OMDA) Launches 7.9M Share IPO at $18-$20/sh

